Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: NDAC

This article was originally published in The Tan Sheet

Executive Summary

NDAC: Acting Executive Secretary for FDA's Nonprescription Drugs Advisory Committee is Rhonda Stover, currently the exec sec for the Anti-Viral Drugs and Psychopharmacologic Drugs Advisory Committees. Former exec sec Andrea Neal has left the position to work on the agency's implementation of the new adverse event reporting system. Kathleen Reedy, exec sec for the Arthritis Drugs and the Endocrinologic and Metabolic Drugs Advisory Committees, will oversee NDAC's Dental Plaque Subcommittee until a replacement is named. The post has been advertised and is expected to be filled in about six weeks, according to the agency...

You may also be interested in...

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts